Pediatric Hematology-Oncology Program, Research Center, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Cancer Prev Res (Phila). 2017 Dec;10(12):738-744. doi: 10.1158/1940-6207.CAPR-17-0121. Epub 2017 Sep 25.
SNPs in are associated with inherited susceptibility to B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Besides, somatic copy number abnormalities (CNA) in genes related to lymphopoiesis (e.g., ) impact patient's outcome. Therefore, this study aimed to investigate an association between germline susceptibility and CNAs in BCP-ALL. The SNPs (rs11978267 and rs4132601) were genotyped in 276 cases and 467 controls. Bone marrow samples were used to determine the presence of somatic abnormalities. The transcript levels were quantified and associated with the SNPs and CNAs. Categorical variables were compared by χ test. ORs were estimated with unconditional logistic regression with 95% confidence interval (CI). The variant allele of rs4132601 conferred increased risk of BCP-ALL (OR, 2.09; 95% CI, 1.16-3.74). Individuals with either rs11978267 or rs4132601 had an increased risk for harboring deletion (OR, 2.80; 95% CI, 1.25-6.23 and OR, 2.88; 95% CI, 1.24-6.69, respectively). Increased risks were observed for individuals harboring both and deletions (OR, 4.90; 95% CI, 1.65-14.55, rs11978267 and OR, 5.80; 95% CI, 1.94-17.41, rs4132601). Germline genetic variation increases the risk for childhood ALL in general, but also acts as a susceptibility factor bound for risk of specific somatic alterations. These findings provide new insight into the development of childhood ALL regarding causal variants and the biological basis of the risk association, offering the opportunity for future tailored research. .
SNPs 与 B 细胞前体急性淋巴细胞白血病(BCP-ALL)的遗传易感性相关。此外,与淋巴发生相关的基因的体细胞拷贝数异常(CNA)(例如 )会影响患者的预后。因此,本研究旨在探讨 BCP-ALL 中胚系易感性与 CNA 之间的关联。在 276 例病例和 467 例对照中检测了 SNPs(rs11978267 和 rs4132601)的基因型。使用骨髓样本确定体细胞异常的存在。定量检测 转录水平,并与 SNPs 和 CNAs 相关联。通过 χ 检验比较分类变量。使用无条件逻辑回归估计 OR 及其 95%置信区间(CI)。 rs4132601 的变体等位基因增加了 BCP-ALL 的风险(OR,2.09;95%CI,1.16-3.74)。携带 rs11978267 或 rs4132601 的个体发生 缺失的风险增加(OR,2.80;95%CI,1.25-6.23 和 OR,2.88;95%CI,1.24-6.69)。携带 和 缺失的个体风险增加(OR,4.90;95%CI,1.65-14.55,rs11978267 和 OR,5.80;95%CI,1.94-17.41,rs4132601)。胚系遗传变异总体上增加了儿童 ALL 的风险,但也作为特定体细胞改变风险的易感性因素。这些发现为儿童 ALL 的发展提供了关于因果变异和风险关联的生物学基础的新见解,为未来的定制研究提供了机会。